SG3 Management’s Gilead Sciences GILD Stock Holding History

SG3 Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-52,000	Closed	-$3.78M	–	1117
2021 Q4	$3.78M	Buy	+52,000	New	+$3.58M	0.08%	227
2021 Q3	–	Sell	-30,000	Closed	-$2.07M	–	1087
2021 Q2	$2.07M	Sell	30,000 -30,000	-50%	-$2M	0.07%	308
2021 Q1	$3.88M	Buy	+60,000	New	+$3.87M	0.1%	240
2017 Q3	–	Sell	-6,500	Closed	-$460K	–	204
2017 Q2	$460K	Buy	+6,500	New	+$433K	0.12%	143
2017 Q1	–	Sell	-20,000	Closed	-$1.43M	–	266
2016 Q4	$1.43M	Buy	+20,000	New	+$1.49M	0.23%	75

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SG3 Management's GILD Position: Q2 2022 in Review

SG3 Management sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 5,500 shares — an estimated $327K sold.

SG3 Management first reported a position in GILD in Q3 2020 and held it in 6 quarters. The position peaked at $2M in Q4 2021. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

SG3 Management reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
SG3 Management sold 5,500 Gilead Sciences shares in Q2 2022, an estimated $327K.
SG3 Management first reported a position in Gilead Sciences in Q3 2020 and held it in 6 quarters.
SG3 Management's Gilead Sciences position peaked at $2M in Q4 2021.
1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.